Stanford GMIX Project Group Visit ZenoWell
Date: August 19, 2025
Location: ZenoWell Innovation Center
Overview
A Stanford GMIX (Global Management Immersion Experience) student group with backgrounds in Biomedical Engineering, Medicine, Neuroscience, and AI visited ZenoWell to engage in focused discussions on AI-driven wearable neurotechnology for cognitive health, early neurological risk screening, recovery support, and emotion-aware monitoring. The visit featured technology demos, interactive Q&A, and an informal cultural segment—warmly assisted by ZenoWell’s resident pet companions.
Visit Highlights
-
Live demo of flexible vagus nerve stimulation device and multimodal (EEG / EMG / EGG / Respiratory) signal acquisition
-
Real-time lightweight inference for sleep staging and stress trend indicators
-
Discussion on AI, big data, wearable device, and closed-loop neuromodulation.
-
Dialogue on clinical translation speed, user adherence metrics, and soft neuro-interface paradigms.
-
Informal engagement fostering innovation culture and well-being.
Looking Ahead
Both sides expressed interest in exploring a focused collaboration in the 2026 GMIX cycle, aiming to prototype a data-driven micro-pilot around personalized neuro-digital biomarkers.
About Stanford GMIX
The Stanford Graduate School of Business GMIX program places students in immersive, short-term global project engagements to solve real organizational challenges at the intersection of strategy, innovation, and impact.
Publicación anterior
ICP 2024 – ZenoWell cofounder Presents Breakthrough Research on ASD and Neuroimaging
Siguiente publicación
ZenoWell Founder Presents on Vagus Nerve Regulation and Neurofeedback at ACAN 2026
Publicaciones relacionadas
Supporting Long-Term Care in Chronic Gastrointestinal Health
Event: 3rd Annual Virtual Gastroparesis ConferenceHost: G-PACT (Gastroparesis Patient Association for Cures and Treatments)Date: March 21, 2026Time: 10:00 am – 2:00 pm (EST)Format: Online...
Mar 06 2026
ZenoWell Founder Presents on Vagus Nerve Regulation and Neurofeedback at ACAN 2026
Date: June 5–6, 2026Location: Opatija, CroatiaEvent: 4th Annual Conference for Applied Neurofeedback (ACAN 2026)Official Conference Website: https://www.acan.beemedic.com/content ZenoWell’s founder was invited to speak at...
Mar 04 2026
ICP 2024 – ZenoWell cofounder Presents Breakthrough Research on ASD and Neuroimaging
Date: July 21 – 26, 2024 Location: O₂ universum，Prague, Czech Republic At the 33rd International Congress of Psychology (ICP 2024), held once every four...
Jul 30 2025
CES 2025 – ZenoWell Showcases the Future of Wearable Neurotechnology
Date: January 9–12, 2025 Location: Digital Health Pavilion, CES, Las Vegas Convention Center, Las Vegas, USA ZenoWell made its official debut at CES 2025,...
Jul 25 2025
OHBM 2025 – ZenoWell Presents Breakthrough Research on taVNS and Brain Modulation
Date: June 23–27, 2025 Location: Brisbane Convention & Exhibition Centre, Brisbane, Australia At the Annual Meeting of the Organization for Human Brain Mapping (OHBM)...
Jul 25 2025
IFA 2025 – ZenoWell to Unveil the Future of Wearable Neurotech in Berlin
Date: September 5–9, 2025 Location: Messe Berlin, Berlin, Germany Exhibition Area: IFA Health & Wellness Tech Pavilion Registration Link: https://ifa-berlin-2025.reg.buzz/ ZenoWell is excited to...
Jul 25 2025
CES 2026 – ZenoWell regresa a Las Vegas con innovaciones taVNS de vanguardia
Fechas: 6–9 de enero de 2026Ubicación: Las Vegas Convention Center, Las Vegas, EE. UU.Área de exhibición: Digital Health PavilionCandidatura al premio: CES Innovation Award...
Jul 25 2025
